IMI prevention of myopia and its progression

JB Jonas, M Ang, P Cho… - … & visual science, 2021 - iovs.arvojournals.org
The prevalence of myopia has markedly increased in East and Southeast Asia, and
pathologic consequences of myopia, including myopic maculopathy and high myopia …

Myopia

PN Baird, SM Saw, C Lanca, JA Guggenheim… - Nature reviews Disease …, 2020 - nature.com
Myopia, also known as short-sightedness or near-sightedness, is a very common condition
that typically starts in childhood. Severe forms of myopia (pathologic myopia) are associated …

[HTML][HTML] Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial

Y Jiang, Z Zhu, X Tan, X Kong, H Zhong, J Zhang… - Ophthalmology, 2022 - Elsevier
Purpose To assess the efficacy and safety of repeated low-level red-light (RLRL) therapy in
myopia control in children. Design Multicenter, randomized, parallel-group, single-blind …

Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial

JC Yam, XJ Zhang, Y Zhang, BHK Yip, F Tang… - Jama, 2023 - jamanetwork.com
Importance Early onset of myopia is associated with high myopia later in life, and myopia is
irreversible once developed. Objective To evaluate the efficacy of low-concentration …

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

J Németh, B Tapasztó, WA Aclimandos… - European Journal …, 2021 - journals.sagepub.com
The prevalence of myopia is increasing extensively worldwide. The number of people with
myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 …

Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report

JC Yam, XJ Zhang, Y Zhang, YM Wang, SM Tang, FF Li… - Ophthalmology, 2022 - Elsevier
Purpose (1) To compare the efficacy of continued and stopping treatment for 0.05%, 0.025%,
and 0.01% atropine during the third year.(2) To evaluate the efficacy of continued treatment …

[HTML][HTML] Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study

X Zhang, SSL Cheung, HN Chan, Y Zhang… - British Journal of …, 2022 - bjo.bmj.com
Background The impacts of social restrictions for COVID-19 on children's vision and lifestyle
remain unknown. Aims To investigate myopia incidence, spherical equivalent refraction …

BCLA CLEAR-Orthokeratology

SJ Vincent, P Cho, KY Chan, D Fadel… - Contact Lens and …, 2021 - Elsevier
Orthokeratology (ortho-k) is the process of deliberately reshaping the anterior cornea by
utilising specialty contact lenses to temporarily and reversibly reduce refractive error after …

Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial

MX Repka, KK Weise, DL Chandler, R Wu… - JAMA …, 2023 - jamanetwork.com
Importance Controlling myopia progression is of interest worldwide. Low-dose atropine eye
drops have slowed progression in children in East Asia. Objective To compare atropine …

Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)

J Rappon, C Chung, G Young, C Hunt… - British Journal of …, 2023 - bjo.bmj.com
Background Mutations in the L/M cone opsin gene array cause abnormally high perceived
retinal contrast and the development of myopia. Environmental factors may also lead to high …